Project Details
Description
Prospective, multicentre, randomised, double-blind, placebocontrolled, 2-parallel groups, phase 3 study to compare efficacy and safety of masitinib to placebo in the treatment of grade 2-3 non-resectable mast cell tumors in dogs not previously treated by
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/16 → 2/28/17 |
Funding
- AB SCIENCES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.